DC leakage levels in early medical device platforms were at tolerable levels; however, lower levels are now required. By utilizing
Vishay’s proprietary multi-array packaging (MAP), the new TM8 devices realize significant reduction in DC leakage and better stability. Leveraging the patented MAP assembly technology,
the TM8 capacitors offer a robust design for the highest possible reliability and efficiency in these applications. In addition,
the devices go through rigorous processing and testing patterned after MIL-PRF-55365.

The TM8 series offers a wide range of capacitance−voltage (CV) ratings from 1 µF / 40 V to 47 µF / 10 V in seven compact case sizes.
The capacitors are well suited for long-term performance in critical applications including implantable medical devices, medical
instrumentation, and military/aerospace systems. Special screening and custom application-specific options are also available
for the TM8 devices.

Offered in tape-and-reel packaging per EIA-481-1, samples and production quantities of the TM8 capacitors are available now, with lead times of 10 weeks for larger orders.

Vishay Intertechnology, Inc., a Fortune 1000 Company listed on the NYSE (VSH), is one of the world's largest manufacturers
of discrete semiconductors (diodes, MOSFETs, and infrared optoelectronics) and passive electronic components (resistors, inductors,
and capacitors). These components are used in virtually all types of electronic devices and equipment, in the industrial,
computing, automotive, consumer, telecommunications, military, aerospace, power supplies, and medical markets. Vishay’s product
innovations, successful acquisition strategy, and "one-stop shop" service have made it a global industry leader. Vishay can
be found on the Internet at www.vishay.com.